Patricia Brunker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patricia Brunker has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Brian C. Healy
Department of Neurology, Mass General Brigham, Boston, MA, 02115, USA
2 shared publications - Crystal M. North
Massachusetts General Hospital Pulmonary and Critical Care Medicine Boston, MA
2 shared publications - Henry Paik
Department of Information Technology, Research Information Science and Computing, Mass General Brigham, Boston, Massachusetts
2 shared publications - Julia Collins
Department of Pathology, Blood Transfusion Service, Massachusetts General Hospital, Boston, Massachusetts
2 shared publications - Kenneth Tierney Shelton
Department of Anesthesiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
2 shared publications - Kristen N. Ruby
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
2 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70146
Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use
Prior surveys of chronic automated red blood cell exchange (RCE) for patients with sickle cell disease (SCD) have identified considerable procedural variability, especially with the use of isovolemic hemodilution red blood cell exchange (IHD‐RCE). We conducted a survey of chronic RCE practices among American Society for Apheresis (ASFA) members to identify opportunities for practice harmonization and future studies. The ASFA SCD Research Subcommittee developed a 72‐item survey of chronic RCE practices, with a focus on IHD‐RCE. The survey was validated internally and distributed by email to all ASFA members from September 2024 to February 2025. One survey response from each institution was retained for data analysis. Descriptive statistics were performed. Sixty‐two survey responses, including three from international institutions, were retained for analysis. Sixty‐one percent of respondents (38/62) reported using at least one fixed RCE target, with end hematocrit being the most common fixed parameter (40%, 25/62), followed by fraction of cells remaining (31%, 19/62) and hemoglobin S% (27%, 17/62). Most respondents (60%, 37/61) performed IHD‐RCE at their institution, though other details such as the minimum hematocrit, exclusion criteria, and response to adverse effects were variable. Consistent pre‐ and post‐RCE laboratory monitoring practices were reported. Consistent with earlier surveys, procedural variability in chronic RCE practices for patients with SCD is observed. This highlights opportunities to compare outcomes where practice variability exists. Consensus guidelines based on institutional practices with optimal outcomes should be developed.
- 18 June 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70146
Open AccessVariation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use
Prior surveys of chronic automated red blood cell exchange (RCE) for patients with sickle cell disease (SCD) have identified considerable procedural variability, especially with the use of isovolemic hemodilution red blood cell exchange (IHD‐RCE). We conducted a survey of chronic RCE practices among American Society for Apheresis (ASFA) members to identify opportunities for practice harmonization and future studies. The ASFA SCD Research Subcommittee developed a 72‐item survey of chronic RCE practices, with a focus on IHD‐RCE. The survey was validated internally and distributed by email to all ASFA members from September 2024 to February 2025. One survey response from each institution was retained for data analysis. Descriptive statistics were performed. Sixty‐two survey responses, including three from international institutions, were retained for analysis. Sixty‐one percent of respondents (38/62) reported using at least one fixed RCE target, with end hematocrit being the most common fixed parameter (40%, 25/62), followed by fraction of cells remaining (31%, 19/62) and hemoglobin S% (27%, 17/62). Most respondents (60%, 37/61) performed IHD‐RCE at their institution, though other details such as the minimum hematocrit, exclusion criteria, and response to adverse effects were variable. Consistent pre‐ and post‐RCE laboratory monitoring practices were reported. Consistent with earlier surveys, procedural variability in chronic RCE practices for patients with SCD is observed. This highlights opportunities to compare outcomes where practice variability exists. Consensus guidelines based on institutional practices with optimal outcomes should be developed.
- 16 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 822-828
Time-Varying Associations Between Selected Clinical Indicators And In-Hospital Mortality During The Early Period Of Critical Care
BACKGROUND: Many patients in intensive care units (ICUs) are clinically unstable during the first several days of ICU care. The goal of this study was to describe how the association between selected clinical variables and in-hospital mortality varied across short, sequential time periods during the early phase of ICU care. METHODS: Retrospective analysis of 19,439 ICU encounters among 17,769 patients, aged 18 to 102, who were treated in three ICUs at a single academic medical center during the years 2018 to 2023. Each encounter was segmented into brief intervals of care defined by time between complete blood count results. We analyzed 144,157 time intervals representing the early period of care up to the first 20 consecutive time intervals. For each time interval, we performed multivariable logistic regression to estimate the odds ratios of association between nine selected clinical variables and in-hospital death. Variables included patient demographics, laboratory results, and treatment modalities previously found to be associated with ICU survival in published studies. Both current and previous exposure to life-support treatments (mechanical ventilation, pressors, or dialysis) and interactions among life-support treatments were also investigated as variables. RESULTS: The mean duration of the analyzed time intervals of care was 512 ±215 minutes (median 574, IQR 326–720 minutes). One third of in-hospital mortality among ICU patients occurred during the first 20 time intervals of care. The odds ratios for death for age, sex, platelet count, hemoglobin, and transfusion ranged from 1.01 to 1.35 with small variations across periods of care, whereas the odds ratios for ventilator use, dialysis, pressors, and bilirubin varied more widely from 1.43 to 4.75. CONCLUSION: The strength of association between selected clinical variables and in-hospital mortality varied with time during early periods of ICU care.
- 16 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 822-828
Time-Varying Associations Between Selected Clinical Indicators And In-Hospital Mortality During The Early Period Of Critical Care
BACKGROUND: Many patients in intensive care units (ICUs) are clinically unstable during the first several days of ICU care. The goal of this study was to describe how the association between selected clinical variables and in-hospital mortality varied across short, sequential time periods during the early phase of ICU care. METHODS: Retrospective analysis of 19,439 ICU encounters among 17,769 patients, aged 18 to 102, who were treated in three ICUs at a single academic medical center during the years 2018 to 2023. Each encounter was segmented into brief intervals of care defined by time between complete blood count results. We analyzed 144,157 time intervals representing the early period of care up to the first 20 consecutive time intervals. For each time interval, we performed multivariable logistic regression to estimate the odds ratios of association between nine selected clinical variables and in-hospital death. Variables included patient demographics, laboratory results, and treatment modalities previously found to be associated with ICU survival in published studies. Both current and previous exposure to life-support treatments (mechanical ventilation, pressors, or dialysis) and interactions among life-support treatments were also investigated as variables. RESULTS: The mean duration of the analyzed time intervals of care was 512 ±215 minutes (median 574, IQR 326–720 minutes). One third of in-hospital mortality among ICU patients occurred during the first 20 time intervals of care. The odds ratios for death for age, sex, platelet count, hemoglobin, and transfusion ranged from 1.01 to 1.35 with small variations across periods of care, whereas the odds ratios for ventilator use, dialysis, pressors, and bilirubin varied more widely from 1.43 to 4.75. CONCLUSION: The strength of association between selected clinical variables and in-hospital mortality varied with time during early periods of ICU care.
- 11 December 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (6) , e70080
A Web‐Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective Assessment
A major challenge in hematopoietic progenitor cell apheresis is determining the whole blood (WB) volume to process to achieve a CD34+ cell collection goal. We developed a web‐based calculator app that uses the Collection Efficiency 2 (CE2) model to estimate personalized WB processing volumes needed to reach a prescribed CD34+ cell collection goal. Retrospective evaluation of the app using collection data from two academic medical centers showed that actual processed WB volumes were frequently higher than the app's recommendations. The frequency of potential under‐collection events is predicted to be low had the app‐calculated volumes been utilized. Our findings suggest that using the app's recommendations may lower total WB processing volumes, reducing over‐collection and time spent on the apheresis machine, while maintaining a low under‐collection risk profile.
- 11 December 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (6) , e70080
A Web‐Based Calculator for Hematopoietic Progenitor Cell Collections: App Development and Retrospective Assessment
A major challenge in hematopoietic progenitor cell apheresis is determining the whole blood (WB) volume to process to achieve a CD34+ cell collection goal. We developed a web‐based calculator app that uses the Collection Efficiency 2 (CE2) model to estimate personalized WB processing volumes needed to reach a prescribed CD34+ cell collection goal. Retrospective evaluation of the app using collection data from two academic medical centers showed that actual processed WB volumes were frequently higher than the app's recommendations. The frequency of potential under‐collection events is predicted to be low had the app‐calculated volumes been utilized. Our findings suggest that using the app's recommendations may lower total WB processing volumes, reducing over‐collection and time spent on the apheresis machine, while maintaining a low under‐collection risk profile.
- 22 August 2023
- Published by Wiley in Transfusion
- Vol. 63 (9) , 1661-1676
Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals
Background: While prior studies of platelet transfusion in critical care have focused on transfusions given, proper analysis of clinical transfusion practice also requires consideration of the decision not to transfuse.Study Design and Methods: We introduce a new method to assess transfusion practice based on decision time intervals (DTIs). Each patient's intensive care (ICU) stay was segmented into a series of DTIs defined by a time interval following results of a complete blood count (CBC). We studied the presence of 17 clinical factors during each DTI whether transfusion was given or not. We used a generalized linear mixed model to assess the most influential clinical triggers for platelet transfusion.Results: Among 6125 ICU patients treated between October 2016 and October 2021, we analyzed 39,745 DTIs among patients (n = 2921) who had at least one DTI with thrombocytopenia (≤150,000/μL). We found no association between platelet count and two markers of bleeding: drop in hemoglobin and chest tube drainage. We found that the majority of DTIs were associated with no platelet transfusion regardless of the platelet count; that no specific platelet value triggered transfusion; but rather that multiple clinical factors in conjunction with the platelet count influenced the decision to transfuse.Discussion: DTI analysis represents a new method to assess transfusion practice that considers both transfusions given and not given, and that analyzes clinical circumstances present when decisions regarding transfusion are made. The method is easily adapted to blood components other than platelet transfusions and is easily extended to other ICU and other hospital settings.
- 22 August 2023
- Published by Wiley in Transfusion
- Vol. 63 (9) , 1661-1676
Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals
Background: While prior studies of platelet transfusion in critical care have focused on transfusions given, proper analysis of clinical transfusion practice also requires consideration of the decision not to transfuse.Study Design and Methods: We introduce a new method to assess transfusion practice based on decision time intervals (DTIs). Each patient's intensive care (ICU) stay was segmented into a series of DTIs defined by a time interval following results of a complete blood count (CBC). We studied the presence of 17 clinical factors during each DTI whether transfusion was given or not. We used a generalized linear mixed model to assess the most influential clinical triggers for platelet transfusion.Results: Among 6125 ICU patients treated between October 2016 and October 2021, we analyzed 39,745 DTIs among patients (n = 2921) who had at least one DTI with thrombocytopenia (≤150,000/μL). We found no association between platelet count and two markers of bleeding: drop in hemoglobin and chest tube drainage. We found that the majority of DTIs were associated with no platelet transfusion regardless of the platelet count; that no specific platelet value triggered transfusion; but rather that multiple clinical factors in conjunction with the platelet count influenced the decision to transfuse.Discussion: DTI analysis represents a new method to assess transfusion practice that considers both transfusions given and not given, and that analyzes clinical circumstances present when decisions regarding transfusion are made. The method is easily adapted to blood components other than platelet transfusions and is easily extended to other ICU and other hospital settings.
- Open Access
- 8 August 2021
- Published by Wiley in Transfusion
- Vol. 61 (8) , 2223-2228
Finding platelets: Don't let the perfect be the enemy of the good
See article on page 2307–2316, in this issue
- 8 August 2021
- Published by Wiley in Transfusion
- Vol. 61 (8) , 2223-2228
Open AccessFinding platelets: Don't let the perfect be the enemy of the good
See article on page 2307–2316, in this issue